MedTrace Logo

Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer

NCT00579462 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 281

Last updated 2010-12-01

No results posted yet for this study

Summary

The purpose of this study is to study whether the presence of lung cancer in your body can be detected by testing the blood, and if the results of these blood tests change as your tumor shrinks or grows.

Conditions

Interventions

OTHER

Blood and Tissue studies

Blood will be collected from participating patients at baseline, as close as possible to the date of their baseline radiologic assessment. Three follow-up blood collections will be drawn, each within 7-10 days of each follow-up radiologic evaluation.

Sponsors & Collaborators

Principal Investigators

  • Christopher Azzoli, M.D. · Memorial Sloan Kettering Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-01-31
Primary Completion
2010-11-30
Completion
2010-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00579462 on ClinicalTrials.gov